Steven Gallinger

Researcher

Related Research

Related News & Events

Research Highlight|February 10, 2022

Gut bacteria linked to immune suppression in pancreatic cancer: Study

Lactobacillus – a type of bacteria thought to promote gut health – can alter the function of immune cells called macrophages in the pancreatic tumour ...

Research Highlight|June 08, 2021

Study identifies biomarkers that predict which pancreatic cancer patients with germline BRCA mutations will benefit from personalized therapies using platinums and PARP inhibitors

A new study published in Clinical Cancer Research (October 2020) provides insight into which pancreatic cancer patients with germline BRCA mutations w...

Research Highlight|December 14, 2020

Study reveals unique mutational pattern in patients with early-onset pancreatic cancer

TFRI-funded researchers have found that patients with early-onset pancreatic cancer have a distinct mutational pattern in a gene called CDKN2A. This d...

Research Highlight|April 20, 2020

Pancreatic cancer researchers encouraged by new T-cell finding that identifies patients with hallmarks of an antitumour response

A small subset of patients with pancreatic cancer exhibit a T-cell inflamed profile, a finding that could open the door for the potential use of immun...

Research Highlight|January 14, 2020

Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer

Toronto-based researchers partly funded by the TFRI have discovered detailed new information about the subtypes of pancreatic cancer.

All News & Events